Related Experiment Video
Updated: Nov 28, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Lipoprotein(a) and Cardiovascular Disease
1Department of Clinical Biochemistry.
Insights
High lipoprotein(a) levels significantly increase cardiovascular disease risk, impacting over a billion people. Current treatments do not target lipoprotein(a), highlighting an unmet medical need for effective therapies.
Area of Science:
- Cardiology
- Genetics
- Epidemiology
Background:
- High lipoprotein(a) concentrations affect 10%-20% of the population.
- A causal link to ischemic cardiovascular disease is suspected.
- Lipoprotein(a) is not currently a therapeutic target for cardiovascular disease prevention.
Purpose of the Study:
- To review evidence supporting a causal role of lipoprotein(a) in cardiovascular disease.
- To discuss lipoprotein(a) measurement methods.
- To explore future therapeutic strategies for lowering lipoprotein(a).
Main Methods:
- Review of genetic epidemiologic studies.
- Analysis of mechanistic and observational data.
- Discussion of validated lipoprotein(a) assays.
Main Results:
- Strong evidence from genetic, mechanistic, and observational studies supports a causal role of lipoprotein(a) in cardiovascular disease, including coronary heart disease, peripheral arterial disease, aortic valve stenosis, and ischemic stroke.
- High lipoprotein(a) predicts 2- to 3-fold increased risk for myocardial infarction, peripheral arterial disease, and aortic valve stenosis.
- Accurate lipoprotein(a) measurement requires validated assays traceable to a common calibrator.
Conclusions:
- Lipoprotein(a) is causally linked to cardiovascular disease development.
- Standardized, validated assays are crucial for risk assessment.
- Further research, including randomized trials, is needed to evaluate lipoprotein(a)-lowering therapies.
Background:
High lipoprotein(a) concentrations present in 10%-20% of the population have long been linked to increased risk of ischemic cardiovascular disease. It is unclear whether high concentrations represent an unmet medical need. Lipoprotein(a) is currently not a target for treatment to prevent cardiovascular disease.
Content:
The present review summarizes evidence of causality for high lipoprotein(a) concentrations gained from large genetic epidemiologic studies and discusses measurements of lipoprotein(a) and future treatment options for high values found in an estimated >1 billion individuals worldwide.
Summary:
Evidence from mechanistic, observational, and genetic studies support a causal role of lipoprotein(a) in the development of cardiovascular disease, including coronary heart disease and peripheral arterial disease, as well as aortic valve stenosis, and likely also ischemic stroke. Effect sizes are most pronounced for myocardial infarction, peripheral arterial disease, and aortic valve stenosis where high lipoprotein(a) concentrations predict 2- to 3-fold increases in risk. Lipoprotein(a) measurements should be performed using well-validated assays with traceability to a recognized calibrator to ensure common cut-offs for high concentrations and risk assessment. Randomized cardiovascular outcome trials are needed to provide final evidence of causality and to assess the potential clinical benefit of novel, potent lipoprotein(a) lowering therapies.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements

